Heart-lung Machine Market Size & Share 2026-2035

Heart-lung Machine Market Size

The global heart-lung machine market was valued at USD 385.3 million in 2025. The market is expected to grow from USD 400.2 million in 2026 to USD 606.7 million in 2035, growing at a CAGR of 4.7% during the forecast period, according to the latest report published by Global Market Insights Inc.

The market growth is attributed to the increasing prevalence of cardiovascular disease and the growing number of organ transplant surgeries, among other contributing factors.
 

A heart-lung machine, also known as a cardiopulmonary bypass (CPB) machine, is a medical device used for open-heart surgeries to temporarily take over the functions of the heart and lungs. The heart-lung machine performs the essential tasks of oxygenating the blood, removing carbon dioxide, and circulating the oxygenated blood back into the patient's body.
 

The key players in the heart-lung machine market are FRESENIUS MEDICAL CARE, LivaNova, Medtronic, NIPRO, and TERUMO. These players compete in the market through continuous product innovation, strategic mergers and acquisitions, geographic expansion, and investments in advanced technologies, while also focusing on clinical collaborations and regulatory approvals to strengthen their global market presence.
 

The market increased from USD 343.2 million in 2022 to USD 369.8 million in 2024, with a historic growth rate of 3.8%. The market has shown steady expansion in recent years, driven by the growing geriatric population, which is highly susceptible to cardiovascular diseases (CVDs).
 

The global burden of CVDs has been steadily rising due to factors such as aging populations, sedentary lifestyles, poor dietary habits, and increasing rates of hypertension and diabetes. According to the World Health Organization (WHO), cardiovascular diseases account for approximately 17.9 million deaths annually, representing 32% of all global deaths. These conditions often necessitate surgeries that require the use of heart-lung machines for effective cardiac support, driving the demand for these cardiovascular devices.

Heart-lung Machine Market Trends

Technological advancements in heart-lung machines are a key growth driver for the market, as innovations in design, functionality, and performance continue to enhance the capabilities of these critical devices. These advancements have improved the safety, efficiency, and ease of use of heart-lung machines, making them an essential tool in cardiovascular surgeries and other complex procedures.
 

• Recent innovations in oxygenator technology have resulted in more efficient and compact devices that provide better oxygenation during surgery. Enhanced blood pump designs have also improved circulation stability and reduced the risk of complications. These advancements have made heart-lung machines more reliable, supporting their increasing adoption in a wide range of surgeries.
   
• Additionally, modern heart-lung machines are equipped with advanced monitoring systems that provide real-time data on patient vitals, blood flow, and oxygenation levels. These systems not only improve surgical precision but also ensure greater patient safety during complex procedures. Automation features have minimized human error, allowing surgeons and healthcare teams to focus on other critical aspects of surgery.
   

Heart-lung Machine Market Analysis

Based on type, the heart-lung machine market is segmented into single roller pump and double roller pump. The single roller pump segment is expected to drive business growth and expand at a CAGR of 4.4%, reaching over USD 354 million by 2035, driven by its widespread use in cardiopulmonary bypass procedures, reliability in maintaining controlled blood flow, and the increasing number of cardiac surgeries globally.
 

• Single roller pumps have a long-standing history of reliability in maintaining consistent blood flow during surgeries. Their simple yet effective mechanism ensures stable extracorporeal membrane oxygenation, which is essential in critical procedures requiring prolonged extracorporeal circulation.
   
• Compared to alternative pumping mechanisms, single roller pumps are more cost-effective, making them accessible to a broader range of healthcare facilities, including those in emerging markets. Their affordability does not compromise performance, ensuring their continued dominance in the market.
   
• The double roller pump segment was valued at USD 153.9 million in 2025 and is expected to reach USD 252.7 million by 2035. The segment is anticipated to witness steady growth due to its ability to provide more stable and consistent blood flow during complex cardiac procedures. Increasing demand for advanced cardiopulmonary bypass systems in hospitals and cardiac centers is further supporting segment expansion.
   

Based on application, the heart-lung machine market is segmented into cardiac surgeries, lung surgeries, acute respiratory failure treatment, and other applications. The cardiac surgeries segment dominated the market with a revenue share of 40.2% in 2025.
 

• As conditions like coronary artery disease, heart failure, and valvular heart disease become more prevalent, the demand for cardiac surgeries rises in tandem. According to the Centers for Disease Control and Prevention (CDC), approximately 20.1 million adults aged 20 and older had coronary artery disease in the U.S. in 2023. Central to addressing these intricate medical challenges are heart-lung machines, solidifying their dominance in the market.
   
• Improved healthcare infrastructure and rising healthcare expenditures, particularly in emerging economies, have enhanced the accessibility of advanced surgical procedures. This development has increased the adoption of heart-lung machines in cardiac surgeries worldwide.
   
• The lung surgeries segment was valued at USD 115 million in 2025 and is expected to reach USD 194.2 million by 2035, growing at a CAGR of 5.5% during the forecast period. The growth is driven by the increasing prevalence of lung diseases such as COPD and lung cancer, along with the rising number of thoracic surgical procedures. Advancements in cardiopulmonary bypass technologies and improved surgical outcomes are further supporting the adoption of heart-lung devices in lung surgeries.
   
• The acute respiratory failure treatment segment was valued at USD 72.2 million in 2025 and is expected to reach USD 116.3 million by 2035. The growth is driven by the increasing incidence of severe respiratory disorders, rising ICU admissions, and the growing use of extracorporeal life support systems during critical care management.
   
• The other applications segment is expected to witness steady growth over the forecast period, driven by the expanding use of heart-lung devices in complex cardiovascular procedures, organ transplantation support, and advanced critical care settings. Increasing adoption of extracorporeal circulation technologies and rising surgical volumes across hospitals are further supporting the gradual expansion of this segment.

Based on end use, the heart-lung machine market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment dominated the market in 2025 and is anticipated to reach USD 253.7 million by the end of the forecast period.
 

• Heart-lung machines are crucial in post-transplantation regimens, as they effectively suppress the immune system to prevent the body from rejecting transplanted organs. Their efficacy and reliability make them the first-line choice in immunosuppressive protocols, solidifying their dominance in this segment.
   
• The rising prevalence of end-stage organ failure due to chronic conditions like diabetes, cardiovascular diseases, and liver cirrhosis has led to a surge in organ transplantation rates. This growth directly fuels the demand for heart-lung machines to ensure transplant success and longevity, thereby fueling the market growth.
   
• The ambulatory surgical centers segment was valued at USD 145.6 million in 2025 and is expected to reach USD 243 million by 2035, growing at a CAGR of 5.3% during the forecast period. The growth of this segment is driven by the increasing shift toward minimally invasive cardiac and thoracic procedures performed in outpatient settings. Additionally, advancements in compact heart–lung machines and cost-effective surgical solutions are encouraging ambulatory surgical centers to adopt these devices for efficient perioperative cardiopulmonary support.
   
• The other end users segment is expected to witness steady growth over the forecast period, supported by the increasing adoption of heart-lung devices in specialty cardiac centers, research institutes, and emergency care facilities. Growing investments in advanced surgical infrastructure and the rising demand for cardiopulmonary support technologies are further contributing to the segment’s expansion.

North America Heart-lung Machine Market

North America dominated the heart-lung machine industry, accounting for a market share of 40.7% in 2025.
 

• The U.S. market size reached USD 144.6 million in 2025 and is anticipated to grow at a CAGR of 4.1% from 2026 to 2035.
   
• The country performs a substantial number of cardiac surgeries annually, including coronary artery bypass grafting (CABG) and valve replacements, which necessitate the use of heart-lung machines.
   
• Favorable reimbursement policies, significant R&D investments, and the presence of key market players further bolster the U.S. leadership in the market.
   

Europe Heart-lung Machine Market

The Europe heart-lung machine industry accounted for USD 116.1 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• Europe accounted for a significant share of the ECG devices market, supported by the strong presence of well-established healthcare infrastructure and the growing prevalence of cardiovascular diseases across the region. Countries such as Germany, France, and the U.K. are witnessing increasing adoption of advanced ECG monitoring technologies due to the rising aging population and higher demand for early cardiac diagnosis. Additionally, supportive government healthcare policies and reimbursement frameworks are encouraging hospitals and diagnostic centers to invest in modern ECG equipment.
   
• Furthermore, the region benefits from the presence of leading medical device manufacturers and continuous technological advancements in cardiac monitoring systems. The increasing adoption of portable and wireless ECG devices, along with the integration of digital health platforms for remote cardiac monitoring, is further strengthening market growth across Europe.
   

Asia Pacific Heart-lung Machine Market

The Asia Pacific heart-lung machine industry is anticipated to grow at the highest CAGR of 5.7% during the forecast period.
 

• Asia Pacific is expected to witness rapid growth in the ECG devices market, driven by the large patient population suffering from cardiovascular disorders and the increasing healthcare expenditure in emerging economies such as China, India, and Southeast Asian countries. Growing awareness about early detection of heart diseases and the expansion of diagnostic infrastructure are supporting the adoption of ECG devices across hospitals and clinics.
   
• Additionally, the region is experiencing rising demand for portable and home-based ECG monitoring solutions, particularly in rural and semi-urban areas where access to advanced healthcare facilities is limited. Government initiatives to improve cardiac care services and increase investments in healthcare technology are further accelerating market expansion in the Asia Pacific region.
   

Latin America Heart-lung Machine Market

The Latin America heart-lung machine industry accounted for USD 19 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• Latin America holds a notable share of the ECG devices market, primarily due to the increasing burden of cardiovascular diseases and improving healthcare infrastructure across countries such as Brazil, Mexico, and Argentina. The growing number of diagnostic centers and hospitals adopting advanced cardiac monitoring equipment is contributing to the steady demand for ECG devices in the region.
   
• Moreover, rising healthcare spending and increasing awareness about preventive cardiac health are encouraging the use of ECG systems for routine cardiac screening. The adoption of portable and cost-effective ECG devices is also increasing, particularly in secondary healthcare facilities and outpatient settings.
   

Middle East and Africa Heart-lung Machine Market

The Middle East and Africa heart-lung machine industry accounted for USD 10.3 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• The Middle East & Africa region is witnessing gradual growth in the ECG devices market, driven by the rising prevalence of cardiovascular diseases and improving access to healthcare services. Countries such as the UAE, Saudi Arabia, and South Africa are investing significantly in healthcare infrastructure and advanced diagnostic technologies, which are supporting the demand for ECG devices.
   
• Additionally, increasing government initiatives to strengthen cardiac care services and the expansion of private healthcare providers are contributing to the market’s development. The growing adoption of portable ECG devices and telehealth-enabled cardiac monitoring solutions is also helping expand cardiac diagnostic capabilities across the region.
   

Heart-lung Machine Market Share

The heart-lung machine industry is highly dynamic, with key players like FRESENIUS MEDICAL CARE, LivaNova, Medtronic, NIPRO, and TERUMO, which collectively hold approximately 42% of the total market share. Companies are investing heavily in R&D to develop advanced heart-lung machines with enhanced features such as real-time monitoring, integration with other surgical equipment, and enhanced biocompatibility.
 

Additionally, partnerships with healthcare providers are being forged to improve type accessibility in emerging markets. Regulatory compliance and adherence to international quality standards are crucial aspects of the strategies employed by these companies to cater to a global market. These developments are helping companies meet the increasing demand for safe and efficient heart-lung machines.
 

Heart-lung Machine Market Companies

A few of the prominent players operating in the heart-lung machine industry include:

• BRAILE
• Edwards
• ELITE LIFE CARE
• EUROSETS
• FRESENIUS MEDICAL CARE
• GETINGE
• HEART CARE INDIA CO
• hemovent
• Jarvik HEART
• LivaNova
• Medtronic
• NIPRO
• Palex
• Philips
• raumedic
• TERUMO
   
• LivaNova

LivaNova commands a leading position in the heart‑lung machine market through its next‑generation Essenz  Perfusion System, built upon the globally proven S5  heart‑lung machine platform, which has supported millions of cardiac procedures. The Essenz system integrates individual pump control, intuitive dashboards, continuous data capture, and automated sensor checks, delivering high workflow efficiency and improved perfusion safety.
 

• Medtronic

Medtronic maintains a strong competitive edge through its comprehensive, extensively validated cardiopulmonary bypass product portfolio, including the Affinity Fusion and Affinity NT oxygenation systems, Pixie pediatric oxygenators, Balance biocompatible surfaces, advanced arterial filters, and centrifugal blood pumps, each designed with perfusionist input to maximize safety, efficiency, and reliability. These systems feature innovations such as radial flow oxygenation, low‑prime designs, integrated air‑removal technologies (VARD), and enhanced platelet‑preserving biocompatible coatings, providing superior circuit performance and reduced blood trauma.
 

The heart-lung machine market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Single roller pump
• Double roller pump

Market, By Application

• Cardiac surgeries
• Lung surgeries
• Acute respiratory failure treatment
• Other applications

Market, By End Use

• Hospitals and clinics
• Ambulatory surgical centers
• Other end users
   

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE